Skip to Content

TV 5382 (Abacavir Sulfate and Lamivudine 600 mg / 300 mg)

Pill with imprint TV 5382 is Yellow, Capsule-shape and has been identified as Abacavir Sulfate and Lamivudine 600 mg / 300 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Abacavir/lamivudine is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Abacavir/lamivudine 600 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV 5382

Abacavir sulfate and lamivudine 600 mg / 300 mg TV 5382

Abacavir Sulfate and Lamivudine

Imprint
TV 5382
Strength
600 mg / 300 mg
Color
Yellow
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-5382
Inactive Ingredients
FD&C Yellow No. 6, hypromellose 2910 (6 mPa.s), ferric oxide yellow, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, polysorbate 80, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.